Literature DB >> 17916583

Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons.

Vasanta Subramanian1, Benedict Crabtree, K Ravi Acharya.   

Abstract

Amyotrophic lateral sclerosis (ALS) is a late onset neurodegenerative disorder affecting upper and lower motor neurons (MNs). The molecular mechanisms underlying ALS are poorly understood. Mutations in SOD1 is one of the known causes of ALS but occur only in a very small number of cases of ALS. Interestingly, mutations in human angiogenin (hANG), a member of the ribonuclease A (RNase A) superfamily known to be involved in neovascularization, have been recently reported in patients with ALS, but the effects of these mutations on MN differentiation and survival has not been investigated. We have used the well-characterized pluripotent P19 embryonal carcinoma (EC) cell culture model of neuro-ectodermal differentiation to study the effects of hANG-ALS variants on MN differentiation and survival. Here we report that P19 EC cells induced to differentiate in the presence of hANG and hANG-ALS-associated variants internalize the wild-type and variant proteins. The P19 EC cells differentiate to form neurons but the ability of the neurites to extend and make contacts with neighbouring neurites is compromised when treated with the hANG-ALS variants. In addition, hANG-ALS variants also have a cytotoxic effect on MNs leading to their degeneration. hANG was able to protect neurons from hypoxia-induced cell death, but the variants of hANG implicated in ALS lacked the neuroprotective activity. Our findings show that ANG plays an important role in neurite extension/pathfinding and survival providing a causal link between mutations in hANG and ALS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17916583     DOI: 10.1093/hmg/ddm290

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  58 in total

Review 1.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

2.  Human angiogenin presents neuroprotective and migration effects in neuroblastoma cells.

Authors:  Goang-Won Cho; Byung Yong Kang; Seung Hyun Kim
Journal:  Mol Cell Biochem       Date:  2010-02-20       Impact factor: 3.396

3.  A neuroprotective role for angiogenin in models of Parkinson's disease.

Authors:  Trent U Steidinger; David G Standaert; Talene A Yacoubian
Journal:  J Neurochem       Date:  2010-12-22       Impact factor: 5.372

Review 4.  ALS drug development: reflections from the past and a way forward.

Authors:  Swati Aggarwal; Merit Cudkowicz
Journal:  Neurotherapeutics       Date:  2008-10       Impact factor: 7.620

5.  Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter.

Authors:  Jinghao Sheng; Wenhao Yu; Xiangwei Gao; Zhengping Xu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

Review 6.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

7.  Ribonuclease 4 protects neuron degeneration by promoting angiogenesis, neurogenesis, and neuronal survival under stress.

Authors:  Shuping Li; Jinghao Sheng; Jamie K Hu; Wenhao Yu; Hiroko Kishikawa; Miaofen G Hu; Kaori Shima; David Wu; Zhengping Xu; Winnie Xin; Katherine B Sims; John E Landers; Robert H Brown; Guo-fu Hu
Journal:  Angiogenesis       Date:  2012-11-10       Impact factor: 9.596

8.  Human mast cells synthesize and release angiogenin, a member of the ribonuclease A (RNase A) superfamily.

Authors:  Marianna Kulka; Nobuyuki Fukuishi; Dean D Metcalfe
Journal:  J Leukoc Biol       Date:  2009-07-22       Impact factor: 4.962

Review 9.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

10.  Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis.

Authors:  Rubén Fernández-Santiago; Sabine Hoenig; Peter Lichtner; Anne-Dorte Sperfeld; Manu Sharma; Daniela Berg; Oliver Weichenrieder; Thomas Illig; Katharina Eger; Thomas Meyer; Johanna Anneser; Christoph Münch; Stephan Zierz; Thomas Gasser; Albert Ludolph
Journal:  J Neurol       Date:  2009-04-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.